|
advertisement
|
|
|
| Journal Articles Details
|
| Pharmacogenomics Journals |
| Semin Thromb Hemost. 30(5):591-600 |
Clinical and functional consequences of platelet membrane glycoprotein polymorphisms. |
Yee DL, Bray PF.
Department of Pediatrics, Hematology/Oncology Section, Baylor College of Medicine, Houston, Texas, USA. |
Publication Date: Thursday, October 21, 2004
|
Click here to view MEDLINE citation |
|
More October, 2004 pharmacogenomics journal articles.- Genetic testing in primary care.
by Burke W.
Journal: Annu Rev Genomics Hum Genet. 5:1-14
- Optimized antiretroviral therapy: the role of therapeutic drug monitoring and pharmacogenomics.
by van Heeswijk RP.
Journal: Expert Rev Anti Infect Ther. 1(1):75-81
- Pharmacogenomics and colorectal cancer.
by
Journal: Ann Oncol. 15(suppl_4):iv173-iv177
- Pharmacogenetics of methotrexate.
by Krajinovic M, Moghrabi A.
Journal: Pharmacogenomics. 5(7):819-34
- Renin-angiotensin system gene polymorphisms: relationship with blood pressure and microalbuminuria in telmisartan-treated hypertensive patients.
by Redon J, Luque-Otero M, Martell N, Chaves FJ.
Journal: Pharmacogenomics J. 10 2004;:
- Genotyping technologies: application to biotransformation enzyme genetic polymorphism screening.
by Romkes M, Buch SC.
Journal: Methods Mol Biol. 291:399-414
- Genetic determinants of platelet function in thromboembolic diseases.
by Corral J, González-Conejero R, Vicente V.
Journal: J Biol Regul Homeost Agents. 2004 Apr-Jun;18(2):166-71
- Pharmacogenetics of irinotecan toxicity.
by Marsh S, McLeod HL.
Journal: Pharmacogenomics. 5(7):835-43
- Variable sensitivity of FLT3 activation loop mutations to the small molecule tyrosine kinase inhibitor MLN518.
by Clark JJ, Cools J, Curley DP, Yu JC, Lokker NA, Giese NA, Gilliland DG.
Journal: Blood. 104(9):2867-72
- Jonathan K. C. Knowles discusses the impact of pharmacogenomics on market segmentation.
by Knowles JK.
Journal: Nat Rev Drug Discov. 3(10):822
- Toward the pharmacogenomics of cystic fibrosis - an update.
by Sangiuolo F, D'Apice MR, Gambardella S, Di Daniele N, Novelli G.
Journal: Pharmacogenomics. 5(7):861-78
- Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity.
by Ingelman-Sundberg M.
Journal: Pharmacogenomics J. 10 2004;:
- Pharmacogenetics of selective serotonin reuptake inhibitor response: a 6-month follow-up.
by Serretti A, Zanardi R, Franchini L, Artioli P, Dotoli D, Pirovano A, Smeraldi E.
Journal: Pharmacogenetics. 14(9):607-13
- Individual response to treatment: is it a valid assumption?
by Senn S.
Journal: BMJ. 329(7472):966-8
- Pharmacogenomics of adrenoceptors.
by Flordellis C, Paris H, Karabinis A, Lymperopoulos A.
Journal: Pharmacogenomics. 5(7):803-17
- Pharmacogenomics and drug response in cardiovascular disorders.
by Siest G, Jeannesson E, Berrahmoune H, Maumus S, Marteau JB, Mohr S, Visvikis S.
Journal: Pharmacogenomics. 5(7):779-802
- Microarrays in pharmacogenomics.
by Chen JJ.
Journal: J Biopharm Stat. 14(3):535-7
- Dopamine receptor DRD2 genotype and smoking cessation outcome following treatment with bupropion SR.
by Swan GE, Valdes AM, Ring HZ, Khroyan TV, Jack LM, Ton CC, Curry SJ, McAfee T.
Journal: Pharmacogenomics J. 10 2004;:
- Genetic association studies in epilepsy: "the truth is out there".
by Tan NC, Mulley JC, Berkovic SF.
Journal: Epilepsia. 45(11):1429-42
More pharmacogenomics journal articles ... |
Journal Articles Categories:
Health Informatics Journal Articles |
Telemedicine Journal Articles |
Hospital Information Systems Journal Articles |
Data Protection and Privacy Journals Articles |
Mobile and Wireless Computing Journal Articles |
Medical Decision Making |
Bioinformatics Journal Articles |
Genomics Journal Articles |
Proteomics Journal Articles |
Pharmacogenomics Journal Articles
|